The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy
Cancer Immunology, Immunotherapy · 29.06.2026 · 75 (9)
DOI: 10.1007/s00262-026-04442-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 29.06.2026. Verfasst von Yilin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Lymphopenia, Neoplasms, Immunotherapy, Lymphocytes. Die Arbeit nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiaxing Science and Technology Plan Project, Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine-Oncology, National Clinical Key Specialty Construction Project-Oncology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.
- The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China.
- Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.
- The First Hospital of Jiaxing, Jiaxing, 314001, Zhejiang, People's Republic of China. xuyufen@zjxu.edu.cn.
Förderung
- Jiaxing Science and Technology Plan Project
- Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine-Oncology
- National Clinical Key Specialty Construction Project-Oncology
- Jiaxing Key Laboratory of Oncology Radiotherapy
- Jiaxing First Hospital Key Project
- Jiaxing Provincial-Municipal Co-construction Key Discipline in Medicine—Oncology
- National Clinical Key Specialty Construction Project—Oncology
Zitieren
APA
Chen, Y., Chen, S., Zhang, H., Song, B., & Xu, Y. (2026). The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Cancer Immunology, Immunotherapy, 75(9). https://doi.org/10.1007/s00262-026-04442-8
Vancouver
Chen Y, Chen S, Zhang H, Song B, Xu Y. The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy. Cancer Immunology, Immunotherapy. 2026;75(9). doi:10.1007/s00262-026-04442-8
BibTeX
@article{Chen2026,
author = {Chen, Yilin and Chen, Shuaixuan and Zhang, Hang and Song, Binbin and Xu, Yufen},
title = {The microbiota–lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {9},
doi = {10.1007/s00262-026-04442-8}
}
EUVIMED